Previous 10 | Next 10 |
home / stock / henky / henky news
2023-03-07 13:53:03 ET Henkel AG & Co. KGaA (HENKY) Q4 2022 Results Conference Call March 07, 2023 03:00 AM ET Company Participants Leslie Iltgen - IR Carsten Knobel - CEO Marco Swoboda - CFO Conference Call Participants Guillaume Delmas - UBS ...
2023-03-07 11:31:49 ET Henkel AG ( OTCPK:HENKY ): FY GAAP EPS of €3.90. Revenue of €22.4B. For further details see: Henkel AG GAAP EPS of €3.90, revenue of €22.4B
2023-03-06 10:17:11 ET Major earning expected before the bell on Tuesday include: Canaan ( CAN ) DICK'S Sporting Goods ( DKS ) Sea ( SE ) Alaunos Therapeutics ( TCRT ) Thor Industries ( THO ) For further details see: Notable earnings befor...
Summary Henkel is reporting strong top line growth with all regions and all business segments contributing to top line growth. During its Capital Market Day, Henkel outlined the growth potential for both segments. Although Henkel was clearly struggling in the last few years and grow...
Summary Even more well positioned consumer brands companies are seeing too large volume hits as pricing action means share won by supermarket-branded products. Henkel's adhesives may do alright because these products are harder to commodify, especially those with industrial markets sinc...
Summary H.B. Fuller reported weaker-than-expected revenue as volumes continue to erode, but Fuller's performance wasn't out of line with those of comparables like Sika. The auto end-market should be a healthy one for Fuller in 2023, and packaging and hygiene should be relatively stable,...
Summary Diageo plc and Brown-Forman Corporation, the two famous alcoholic beverages producers, are both market leaders in certain areas. Because of their solid and reliable earnings, their stocks never seem to be cheap. In this detailed comparative analysis, I will discuss the two compa...
Summary Olaplex is expected to increase sales 18% in 2022, and has consistently reported 35%+ net income margins while growing at a CAGR of 70% between 2019-2021. Management mistakes in Q2-2022 created uncertainties about the company's ability to continue growing, but giant untapped gro...
Summary Henkel is a company whose shares you can buy and hold forever. Sales are growing again driven by strong pricing actions, but volumes are declining. Gross and EBIT margins are temporarily depressed as a result of post-pandemic headwinds and the conflict between Russia and Ukr...
Summary Henkel’s pricing power continues to insulate the P&L in a difficult operating environment. The guidance has been raised recently but remains conservative, signaling more beats and raises ahead. M&A presents another key long-term driver of value creation. W...
News, Short Squeeze, Breakout and More Instantly...
Henkel AG & Co KGAA ADR Repstg Ord Shs Company Name:
HENKY Stock Symbol:
OTCMKTS Market:
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
Henkel AG & Co. KGAA ADR (HENKY) is expected to report for Q4 2023
Despite the latest federal interest rate hikes, undervalued stocks with impressive financials are expected to deliver solid returns in the coming months. So, we think it could be wise to scoop up quality stocks Moderna (MRNA), Bayer (BAYRY), Henkel (HENKY), AGCO (AGCO), and Penske Automotive ...